Sunday, August 2, 2015

Do you deliver? Trying to sell more meds, AstraZeneca will host Twitter Chat on home delivery

Mail order medicine is old news. But big pharma's attempts to squeeze every last nickel out of its top selling drugs now includes home delivery of a different sort, and AstraZeneca will host a Twitter Chat at 7 p.m., Thursday (tonight) from @AstraZenecaUS to discuss its program. The hashtag is #AZDirect.

Do you deliver? Trying to sell more meds, AstraZeneca will host Twitter Chat on home delivery

0 comments

Mail order medicine is old news. But big pharma's attempts to squeeze every last nickel out of its top selling drugs now includes home delivery of a different sort, and  AstraZeneca will host a Twitter Chat at 7 p.m., Thursday (tonight) from @AstraZenecaUS to discuss its program. The hashtag is #AZDirect.

Two AstraZeneca executives are scheduled to answer questions about the company's program: Linda Palczuk, a VP for Cornerstone and Commercial Excellence, and Rick R. Suarez, an executive director, GI and Foundation Brands. Through the program called AstraZeneca Direct, the company - via pharmacies and pharmacists, it says - is selling Arimidex and Nexium.

AstraZeneca, which recently fought off a takeover bid by Pfizer, is headquartered in London, but has operations in Wilmington and Newark, Del.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog
David Sell blogs about the region's pharmaceutical industry. Follow him on Facebook.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Reach David at dsell@phillynews.com.

David Sell
Also on Philly.com:
letter icon Newsletter